Diagonal Bio AB (DIABIO) — Cash Flow Reinvestment Rate
Diagonal Bio AB (DIABIO) has a Cash Flow Reinvestment Rate of 0.08x as of March 2024, reinvesting Skr541.00K (capex Skr0.00 plus investments Skr-541.00K) from operating cash flow of Skr6.57 Million. See Diagonal Bio AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Diagonal Bio AB Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Diagonal Bio AB across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Diagonal Bio AB.
Annual Cash Flow Reinvestment Rate for Diagonal Bio AB (2020–2020)
Year-by-year capital reinvestment analysis for Diagonal Bio AB. See DIABIO financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | Skr0.00 | Skr226.67K | Skr0.00 | — |